High Outlier
Strength
6 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173047800
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080On Market Since
1/27/1997
Pharmacological Classes
Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist
Related Drugs
Same classification
MAXALT MLT 10 MG TABLET
Brand
78206014301•Organon LLC
$44.3130
per EA
MAXALT 10 MG TABLET
Brand
78206014201•Organon LLC
$44.4765
per EA
RELPAX 40 MG TABLET
Brand
00049234005•Roerig
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036856•Viatris Specialty LLC
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036896•Viatris Specialty LLC
$77.1492
per EA
RELPAX 20 MG TABLET
Brand
00049233045•Roerig
$77.3165
per EA
RELPAX 20 MG TABLET
Brand
58151036756•Viatris Specialty LLC
$77.3165
per EA
TOSYMRA 10 MG NASAL SPRAY
Brand
70792081261•Tonix Medicines, Inc.
$108.1537
per EA
ZOMIG 2.5 MG NASAL SPRAY
Brand
64896008312•Amneal Pharmaceuticals LLC
$108.5647
per EA
ZOMIG 5 MG NASAL SPRAY
Brand
64896008412•Amneal Pharmaceuticals LLC
$109.5042
per EA